OIA
XBIO icon

OneDigital Investment Advisors’s Xenetic Biosciences XBIO Stock Holding History

OneDigital Investment Advisors’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4
Closed – – 1170
2019
Q2 		$0 Hold
4
– – ﹤0.01% 1284
2019
Q1 		$1K Hold
4
– – ﹤0.01% 1103
2018
Q4 		$1K Hold
4
– – ﹤0.01% 1087
2018
Q3 		$1K Hold
4
– – ﹤0.01% 1026
2018
Q2 		$2K Hold
4
– – ﹤0.01% 1267
2018
Q1 		$1K Hold
4
– – ﹤0.01% 1306
2017
Q4 		$1K Hold
4
– – ﹤0.01% 1222
2017
Q3 		$1K Hold
4
– – ﹤0.01% 1023
2017
Q2 		$1K Buy
+4
New +$1.71K ﹤0.01% 1210

Other funds holding XBIO

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

OneDigital Investment Advisors's XBIO Position: Q3 2019 in Review

OneDigital Investment Advisors sold out of Xenetic Biosciences (XBIO) in Q3 2019, closing a stake of 4 shares.

OneDigital Investment Advisors first reported a position in XBIO in Q2 2017 and held it in 9 quarters. The position peaked at $2K in Q2 2018. 8 funds tracked by Wall St. Rank hold XBIO as of Q3 2019.

  • OneDigital Investment Advisors reported no remaining Xenetic Biosciences position as of Q3 2019 after selling out during the quarter.
  • OneDigital Investment Advisors sold 4 Xenetic Biosciences shares in Q3 2019.
  • OneDigital Investment Advisors first reported a position in Xenetic Biosciences in Q2 2017 and held it in 9 quarters.
  • OneDigital Investment Advisors's Xenetic Biosciences position peaked at $2K in Q2 2018.
  • 8 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2019.

Based on OneDigital Investment Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.